Format

Send to

Choose Destination
  • The following term was not found in PubMed: 2016;118.
Br Med Bull. 2016 Jun;118(1):50-63. doi: 10.1093/bmb/ldw009. Epub 2016 Mar 16.

Chronic granulomatous disease.

Author information

1
Department of Blood Cell Research, Sanquin Blood Supply Organisation, Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, Plesmanlaan 125, 1066 CX Amsterdam, The Netherlands d.roos@sanquin.nl.

Abstract

INTRODUCTION:

Chronic granulomatous disease (CGD) is a primary immunodeficiency characterized by recurrent, life-threatening bacterial and fungal infections of the skin, the airways, the lymph nodes, the liver, the brain and the bones. Frequently found pathogens are Staphylococcus aureus, Aspergillus species, Klebsiella species, Burkholderia cepacia, Serratia marcescens and Salmonella species.

SOURCES OF DATA:

CGD is a rare (∼1:250 000 individuals) disease caused by mutations in any one of the five components of the NADPH oxidase in phagocytic leucocytes. This enzyme generates superoxide and is essential for intracellular killing of pathogens by phagocytes.

AREAS OF AGREEMENT:

CGD patients suffer not only from life-threatening infections, but also from excessive inflammatory reactions.

AREAS OF CONTROVERSY:

Neither the cause of these inflammatory reactions nor the way to treat them is clear.

AREAS TIMELY FOR DEVELOPING RESEARCH:

Patient selection for and timing of bone marrow transplantation along with gene therapy.

KEYWORDS:

IL-1β; NADPH oxidase; autophagy; autoreactive T cells; chronic granulomatous disease; hyperinflammation

PMID:
26983962
PMCID:
PMC5127417
DOI:
10.1093/bmb/ldw009
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center